Key points
- CRS is a common condition in most of the world, leading to a
significant burden on society in terms of healthcare consumption and
productivity loss.
- Most current drugs are used to alleviate inflammation of the nasal
mucosa, with no specific effect on promoting the epithelization or
cilia growth of the nasal mucosa.
- Rh-bFGF can promote division and maintain the growth of cells from
various tissues. However, there is no research regarding the effect of
rh-bFGF on the growth of nasal mucosa or cilia after sinusitis
surgery.
- Rh-bFGF nasal-drops and sprays can quickly and effectively relieve
postoperative symptoms and improve long-term prognosis of patients
with CRSwNP.
- Rh-bFGF nasal-drops are also an effective method for postoperative
patients with eosinophilic CRSwNP.